Følg
Mikkel Højlund
Titel
Citeret af
Citeret af
År
Trends in utilization and dosing of antipsychotic drugs in Scandinavia: comparison of 2006 and 2016
M Højlund, A Pottegård, E Johnsen, RA Kroken, J Reutfors, ...
British journal of clinical pharmacology 85 (7), 1598-1606, 2019
512019
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents
CU Correll, M Solmi, S Cortese, M Fava, M Højlund, HC Kraemer, ...
World Psychiatry 22 (1), 48-74, 2023
462023
Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials
M Højlund, AF Kemp, PM Haddad, JC Neill, CU Correll
The Lancet Psychiatry 8 (6), 471-486, 2021
452021
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review
S Cortese, M Solmi, G Michelini, A Bellato, C Blanner, A Canozzi, ...
World Psychiatry 22 (1), 129-149, 2023
392023
Diagnostic accuracy of focused deep venous, lung, cardiac and multiorgan ultrasound in suspected pulmonary embolism: a systematic review and meta-analysis
C Falster, N Jacobsen, KE Coman, M Højlund, TA Gaist, S Posth, ...
Thorax 77 (7), 679-689, 2022
362022
Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study
H Kildegaard, LC Lund, M Højlund, LG Stensballe, A Pottegård
Bmj 377, 2022
342022
QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy
A Elliott, TJ Mørk, M Højlund, T Christensen, R Jeppesen, N Madsen, ...
CNS spectrums 23 (4), 278-283, 2018
302018
Sodium‐glucose cotransporter‐2 inhibitors and the risk of gout: a Danish population based cohort study and symmetry analysis
LC Lund, M Højlund, DP Henriksen, J Hallas, KB Kristensen
Pharmacoepidemiology and drug safety 30 (10), 1391-1395, 2021
272021
Use of low‐dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator‐controlled cohort study
M Højlund, K Andersen, MT Ernst, CU Correll, J Hallas
World Psychiatry 21 (3), 444-451, 2022
262022
Use of antipsychotics in Denmark 1997–2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses
M Højlund, JH Andersen, K Andersen, CU Correll, J Hallas
Epidemiology and Psychiatric Sciences 30, e28, 2021
242021
Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study
M Højlund, LC Lund, JLE Herping, MB Haastrup, P Damkier, ...
BMJ open 10 (8), e038247, 2020
192020
Association of low-dose quetiapine and diabetes
M Højlund, LC Lund, K Andersen, CU Correll, J Hallas
JAMA Network Open 4 (5), e213209-e213209, 2021
162021
Development and validation of a Nordic multimorbidity index based on hospital diagnoses and filled prescriptions
KB Kristensen, LC Lund, PB Jensen, A Broe, E Rotbain, P Damkier, ...
Clinical Epidemiology, 567-579, 2022
122022
Lung ultrasound to phenotype chronic lung allograft dysfunction in lung transplant recipients. A prospective observational study
JR Davidsen, CB Laursen, M Højlund, TK Lund, KN Jeschke, M Iversen, ...
Journal of Clinical Medicine 10 (5), 1078, 2021
122021
Obstructive hydrocephalus caused by colloid cyst presenting as a schizophrenia-like psychosis
M Højlund, P Hansen, W Krone, L Høgh
Case Reports 2018, bcr-2017-223037, 2018
102018
Use of benzodiazepines and benzodiazepine‐related drugs in the Nordic countries between 2000 and 2020
M Højlund, LS Gudmundsson, JH Andersen, LK Saastamoinen, H Zoega, ...
Basic & Clinical Pharmacology & Toxicology 132 (1), 60-70, 2023
82023
Lithium and the risk of chronic kidney disease: A population‐based case–control study
M Højlund, JS Winkel, M Nybo, J Hallas, DP Henriksen, P Damkier
Basic & Clinical Pharmacology & Toxicology 131 (2), 129-137, 2022
82022
Outcomes in people with eating disorders: a transdiagnostic and disorder‐specific systematic review, meta‐analysis and multivariable meta‐regression analysis
M Solmi, F Monaco, M Højlund, AM Monteleone, M Trott, J Firth, ...
World Psychiatry 23 (1), 124-138, 2024
62024
Ulotaront: a TAAR1/5-HT1A agonist in clinical development for the treatment of schizophrenia
M Højlund, CU Correll
Expert Opinion on Investigational Drugs 31 (12), 1279-1290, 2022
62022
Use of antipsychotics and benzodiazepines in connection to minimising coercion and mechanical restraint in a general psychiatric ward
M Højlund, L Høgh, AB Bojesen, P Munk-Jørgensen, E Stenager
International Journal of Social Psychiatry 64 (3), 258-265, 2018
62018
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20